Catalyst Pharmaceuticals (CPRX) Retained Earnings (2010 - 2026)
Catalyst Pharmaceuticals' (CPRX) quarterly Retained Earnings came in at $489.2 million in Q1 2026, up 2877852.94% YoY from N/an in Q1 2025, and up 1.93% on a QoQ basis from $480.0 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Retained Earnings (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 17 years of Retained Earnings data on file, last reported at $489.2 million in Q1 2026.
- Quarterly Retained Earnings rose 2877852.94% year-over-year to $489.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $489.2 million (up 2877852.94% YoY) and the FY2025 annual result came in at $480.0 million, up 749832.81% from the prior year.
- Retained Earnings rose to $489.2 million in Q1 2026, from $480.0 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $489.2 million in Q1 2026 to a low of -$453000.0 in Q1 2022.
- A 5-year average of $103.0 million and a median of $21500.0 in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 251.35% — and 2026, when it surged 2877852.94%.
- Tracing CPRX's Retained Earnings over 5 years: stood at $24000.0 in 2022, then sank by 41.67% to $14000.0 in 2023, then soared by 357.14% to $64000.0 in 2024, then surged by 749832.81% to $480.0 million in 2025, then advanced by 1.93% to $489.2 million in 2026.
- The last three Retained Earnings figures came in at $489.2 million (Q1 2026), $480.0 million (Q4 2025), and $473.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 489.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 489.22 Mn |
| Dec 31, 2025 | 479.96 Mn |
| Sep 30, 2025 | 473.33 Mn |
| Jun 30, 2025 | 31,000.00 |
| Mar 31, 2025 | -17,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Sep 30, 2023 | 15,000.00 |
| Jun 30, 2023 | 19,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Dec 31, 2022 | 24,000.00 |
| Sep 30, 2022 | 32,000.00 |
| Jun 30, 2022 | -130,000.00 |
| Mar 31, 2022 | -453,000.00 |
| Dec 31, 2021 | -148,000.00 |
| Sep 30, 2021 | 231.17 Mn |
| Jun 30, 2021 | -37,000.00 |
| Mar 31, 2021 | -46.34 Mn |
| Dec 31, 2020 | -53.71 Mn |
| Sep 30, 2020 | -65.14 Mn |